Regulations.gov document
CDER response to Oncopeptides AB"s appeal of CDER"s proposal to withdraw approval of…
Other · FDA-2023-N-3167 · posted Oct 24, 2023
Key facts
| Document ID | FDA-2023-N-3167-0029 |
|---|---|
| Title | CDER response to Oncopeptides AB"s appeal of CDER"s proposal to withdraw approval of Pepaxto |
| Document type | Other |
| Subtype | Correspondence |
| Agency | FDA |
| Docket | FDA-2023-N-3167 |
| Posted | Oct 24, 2023 |
| Comment period opens | Oct 24, 2023 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: